Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The 1st Step of Emerging Technology Ventures

630 views

Published on

  • Be the first to comment

  • Be the first to like this

The 1st Step of Emerging Technology Ventures

  1. 1. 2012 TAMHSC Commercialization Seminar Business Plan Ping Zhou Research Valley Innovation Center The Research Valley Partnership, Inc. Feb 15, 2012v0February 28, 2012 ©2008 The Research Valley Innovation Center
  2. 2. Agenda 1. Stages of New Venture 2. Biotech Product Life Cycle 3. Business Plan 4. Market Analysis 5. An Example of Market AnalysisFebruary 28, 2012 ©2008 The Research Valley Innovation Center
  3. 3. Stages of New Venture 0February 28, 2012 ©2008 The Research Valley Innovation Center
  4. 4. Stages of New Venture • Idea • Pre-formation – Business Plan Gets Started • Formation • 1st Dollar Revenue • Breakeven 0 • Profitability • ExitFebruary 28, 2012 ©2008 The Research Valley Innovation Center
  5. 5. Biotech Product Life Cycle Research Development Commercialization Drug Animal FDA Phase I Phase II Phase III Phase IV Candidates Trials Approval IND submitted NDA submitted Drug launched 2-5 yrs 6-7 yrs 0.4-2 yrsFebruary 28, 2012 ©2008 The Research Valley Innovation Center
  6. 6. An Outline of A Business Plan 1. Executive Summary 2. The Business Model and Financial Goals 3. Market Analysis 4. Solutions 5. Go-to-Market 6. Operations, Production, and Supply 7. Organization 8. Major Milestones with Funding 9. Financial Projections (Entrepreneurship 2011)February 28, 2012 ©2008 The Research Valley Innovation Center
  7. 7. Market Analysis Unmet clinical needs Market size/growth rate/segmentation Existing treatment options Pricing/reimbursementFebruary 28, 2012 ©2008 The Research Valley Innovation Center
  8. 8. An Example – a new drug for AIDS Unmet clinical needs: “In 2007, HIV was the 6th leading cause of death for those ages 25–44, down from #1 in 1994 and 1995” Market size: 40 million globally 1.1 million at US, 50,000 new infections every year Has been stable for a decade $14.1B federal funding for care in 2011 ( Kaiser Family Foundation Fact Sheet: The HIV/AIDS Epidemic in the United States, Dec 2011.)February 28, 2012 ©2008 The Research Valley Innovation Center
  9. 9. An Example – a new drug for AIDS (continued) Existing treatment options: About 30 Anti-retroviral drugs, $9.2B sales in 2010 • Nucleoside analogues: GSK’s AZT • Protease inhibitors: Abbott’s Ritonavir • Fusion inhibitor: Roche’s Fuzion • Entry inhibitors: Pfizer’s Selzentry • Integrase inhibitors: Merck’s Isentress (IMS Health, National Sales Perspectives, Dec 2010)February 28, 2012 ©2008 The Research Valley Innovation Center
  10. 10. An Example – a new drug for AIDS (continued) Who will pay for the drug? What is the price of the drug?February 28, 2012 ©2008 The Research Valley Innovation Center
  11. 11. Thank You! Questions? pzhou@researchvalley.org (979) 260-1755February 28, 2012 ©2008 The Research Valley Innovation Center

×